skip to Main Content
New Study Shows Marijuana’s Benefits to Alzheimer’s

A new study suggests that compounds found in marijuana can stave off the brain damaging effects of Alzheimer’s disease. It’s a promising discovery, but claims that pot can prevent this age-related brain disorder are premature. Put the pipe away, man.

Researchers from the Salk Institute have shown that tetrahydrocannabinol (THC) and other compounds found in marijuana can contribute to the removal of toxic proteins, known as amyloid beta, which have been linked to Alzheimer’s disease. This research offers new insight into the role that inflammation plays in this neurological disorder, which could point the way to new drugs. [Read more at Gizmodo]

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

European Cannabis Round-Up; GW Pharma’s Cannabis Pipeline, Irish CBD In Court, UK Medical Cannabis Price Row, Italian Referendum, Poland And Malta

GW Pharmaceuticals has released further details of its cannabis development pipeline. With Epidiolex approved in the US last year it is also expecting approval for Sativex where two phase 3 trials are ongoing. Work is also underway on the use of Sativex in spinal cord injury, post-traumatic stress disorder and other forms of spasticity. Further…

ICYMI: Adding Marijuana to a NIST Handbook

by Hilary Bricken, Principle at Harris Bricken Not many people get excited about revisions and updates to the very dry National Institute of Standards and Technology  (“NIST”) handbooks. For example, the NIST 44 Handbook contains the “Specifications, Tolerances, and Other Technical Requirements for Weighing and Measuring Devices.” The handbooks are adopted every year at the…

Dama Financial to Acquire GrowFlow

PRESS RELEASE SOUTH SAN FRANCISCO, Calif., Jan. 20, 2022 /PRNewswire/ — Dama Financial (“Dama”), the nation’s largest provider of access to banking and payment solutions for the cannabis industry, has entered into an agreement to acquire GrowFlow Corp. (“GrowFlow”), whose business management and compliance tools have processed more than $3.3 billion for cannabis retailers, cultivators, processors, and distributors. Combining Dama’s…

The REIT Stuff: AFC Gamma CEO Leonard Tannenbaum on Institutional Lending in Cannabis

At the tail-end of our recent phone interview, I mentioned to Leonard Tannenbaum, founder, partner, and CEO of West Palm Beach, Florida-based AFC Gamma (NASDAQ: AFCG), that the term “boutique REIT” had popped into my head as he was explaining how AFC goes about its business and how it differentiates itself from other REITs in…

More Categories

Back To Top
×Close search
Search